This site is intended for health professionals only

Gene linked with depression found


More effective treatments for depression could be developed after scientists discovered a key gene.

Called MKP-1, it was identified through comparing brain tissue samples from dead patients, 21 who were diagnosed with depression and 18 who were depression-free.

The findings, which have been reported in the journal Nature Medicine, show that MKP-1 was twice as active in the brains of those who were depressed.

The gene acts as a block to a molecular pathway that is crucial to the survival and function of neurons.

Study leader Professor Ronald Duman, from Yale University in Connecticut, US, said: “This could be a primary cause, or at least a major contributing factor, to the signalling abnormalities that lead to depression.”

Experts believe multiple physiological processes are involved in clinical depression, which could explain why up to 40% of depressed patients fail to respond to currently available medicines.

Often, it takes weeks or months for an anti-depressant drug to have an effect.

Prof Duman’s team also found that when MKP-1 is deactivated in mice, the animals become resilient to stress.

When the gene was activated, mice exhibited symptoms that mimicked depression.

MKP-1 offered a potential target for a novel class of therapeutic drugs that may prove effective in resistant patients, said the scientists.

Copyright Press Association 2010

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine